Brighter’s Actiste recognized by Fast Company as one of the best World Changing Ideas 2020

Report this content

Brighter is proud to announce that the company’s Actiste service, amongst more than 3,000 entries considered, has been announced one of the Finalists in Fast Company’s 2020 World Changing Ideas Awards in the Health and Wellness category. The company also received an Honorable mention in The best world changing idea overall in Europe, the Middle East and Africa category.

“We are very honored to receive this recognition from Fast Company, one of the world's leading business media brands raising awareness about innovation and businesses driving change in the world,” says Henrik Norström, CEO of Brighter.

For more information:

Contact Brighter:

Henrik Norström, CEO
+46 733 40 30 45

About the award
Every year, Fast Company’s World Changing Ideas Awards honor the businesses and organizations driving change in the world. This year, the contest received 3,000 entries, an all-time record.

About Actiste
Actiste is the world's first complete IoT care solution for monitoring and treating insulin-dependent diabetes. The unit brings together and combine all the necessary functions for diabetes care – blood sampling, blood glucose measurement and drug injection – in a single connected device. 

The solution is based on patented technology for collecting data on specified biomarkers and injected volumes of drugs. With state-of-the-art eSIM technology, Actiste has global out-of-the-box connectivity, making it completely independent of other devices to utilize and share health and treatment data. Actiste received two CE-marks in September 2019 - one for MDD and one for IVDD. The Actiste device is delivered as part of a subscription service. The service includes global connectivity, different levels of data sharing, continuous replenishment of consumables and enables coaching to optimize and improve treatment.

About Brighter AB (publ)
Brighter is a health-tech company from Sweden with a vision of a world where managing chronic diseases is no longer a struggle. We believe a data-centric approach is key to provide smarter care for chronic conditions. Our daily-care solutions facilitate the flow of real-life treatment data between chronic-disease patients, their loved ones and their care providers – improving quality of life, easing the burden on healthcare systems, and opening new opportunities for data-driven research. Brighter is certified under ISO 13485. In 2019 the company won the Swecare Rising Stars Award. 

The Company's shares are listed on Nasdaq First North Growth Market/BRIG. Brighter’s Certified Adviser on Nasdaq OMX First North is Eminova Fondkommission AB, +46 (0)8 – 684 211 10,,


Documents & Links